These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 23621138)

  • 21. Contemporary Drug-Eluting Stent Platforms: Design, Safety, and Clinical Efficacy.
    Partida RA; Yeh RW
    Cardiol Clin; 2017 May; 35(2):281-296. PubMed ID: 28411902
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Percutaneous coronary intervention and stent thrombosis].
    Sugaya T; Igarashi K
    Nihon Rinsho; 2011 Feb; 69(2):275-9. PubMed ID: 21387676
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drug eluting stents: developments and current status.
    Khan W; Farah S; Domb AJ
    J Control Release; 2012 Jul; 161(2):703-12. PubMed ID: 22366546
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stent thrombosis and drug-eluting stents.
    Takayama T; Hiro T; Hirayama A
    J Cardiol; 2011 Sep; 58(2):92-8. PubMed ID: 21839615
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drug-eluting stents.
    García-García HM; Vaina S; Tsuchida K; Serruys PW
    Arch Cardiol Mex; 2006; 76(3):297-319. PubMed ID: 17091802
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stent thrombosis late after implantation of first-generation drug-eluting stents: a cause for concern.
    Camenzind E; Steg PG; Wijns W
    Circulation; 2007 Mar; 115(11):1440-55; discussion 1455. PubMed ID: 17344324
    [No Abstract]   [Full Text] [Related]  

  • 27. Passive and active polymer coatings for intracoronary stents: novel devices to promote arterial healing.
    Pendyala L; Jabara R; Robinson K; Chronos N
    J Interv Cardiol; 2009 Feb; 22(1):37-48. PubMed ID: 19281521
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sirolimus, Tacrolimus and Zotarolimus eluting stents to treat bifurcated lesions: a 7-month clinical outcome comparison.
    Brugaletta S; Burzotta F; Trani C; Todaro D; Talarico G; Porto I; Leone AM; Niccoli G; Mazzari MA; Mongiardo R; Schiavoni G; Crea F
    Minerva Cardioangiol; 2008 Feb; 56(1):35-42. PubMed ID: 18432167
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of coronary bifurcation lesions with drug-eluting stents: insights from the first phase of the prospective multicenter german drug-eluting stent registry.
    Abdel-Wahab M; Nienaber CA; Mostafa AE; Ferenc M; Silber S; Sabin G; Tebbe U; Akin I; Hochadel M; Senges J; Kuck KH; Richardt G;
    J Interv Cardiol; 2012 Aug; 25(4):344-52. PubMed ID: 22409587
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A prospective multicenter parallel-controlled trial of TIVOLI biodegradable-polymer-based sirolimus-eluting stent compared to ENDEAVOR zotarolimus-eluting stent for the treatment of coronary artery disease: 8-month angiographic and 2-year clinical follow-up results.
    Xu B; Dou KF; Han YL; Lü SZ; Yang YJ; Huo Y; Wang LF; Chen YD; Wang HC; Li WM; Chen JY; Wang L; Wang Y; Ge JB; Li W; Gao RL
    Chin Med J (Engl); 2011 Mar; 124(6):811-6. PubMed ID: 21518585
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multicenter international registry of unprotected left main coronary artery percutaneous coronary intervention with everolimus-eluting stents.
    Lee MS; Park KW; Kang SH; Sheiban I; Mahmud E; Thani KB; Cheng R; Cho JH; Jin DK; Gwon HC; Chae IH; Aragon J; Gillis K; Stone GW; Kim HS
    J Invasive Cardiol; 2012 Jul; 24(7):316-9. PubMed ID: 22781468
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incidence of thrombosis after implantation of drug-eluting stents in patients with coronary artery disease.
    Chen JL; Yang YJ; Gao LJ; Huang JH; Qin XW; Qiao SB; Xu B; Yao M; Liu HB; Wu YJ; Yuan JQ; Chen J; You SJ; Dai J; Li JJ; Gao RL
    Chin Med J (Engl); 2008 Nov; 121(21):2144-7. PubMed ID: 19080174
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Are drug-eluting stents associated with a higher rate of late thrombosis than bare metal stents? Late stent thrombosis: a nuisance in both bare metal and drug-eluting stents.
    Serruys PW; Daemen J
    Circulation; 2007 Mar; 115(11):1433-9; discussion 1439. PubMed ID: 17344323
    [No Abstract]   [Full Text] [Related]  

  • 34. Stent thrombosis--risk assessment and prevention.
    Motovska Z; Knot J; Widimsky P
    Cardiovasc Ther; 2010 Oct; 28(5):e92-100. PubMed ID: 20553282
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of stent coating on stent deliverability: direct randomised comparison of drug eluting and bare metal stents using the same stent platform.
    Siminiak T; Link R; Wołoszyn M; Kałmucki P; Baszko A
    Kardiol Pol; 2012; 70(10):998-1002. PubMed ID: 23080088
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Three-year follow-up after treatment of bare-metal stent restenosis with first-generation or second-generation drug-eluting stents.
    Almalla M; Schröder JW; Pross V; Marx N; Hoffmann R
    Coron Artery Dis; 2013 Mar; 24(2):165-70. PubMed ID: 23242011
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stent thrombosis in the era of drug eluting stents.
    Kawaguchi R; Angiolillo DJ; Futamatsu H; Suzuki N; Bass TA; Costa MA
    Minerva Cardioangiol; 2007 Apr; 55(2):199-211. PubMed ID: 17342038
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Four-year clinical outcome of sirolimus- and paclitaxel-eluting stents compared to bare-metal stents for the percutaneous treatment of stable coronary artery disease.
    Simsek C; Onuma Y; Magro M; de Boer S; Battes L; van Domburg RT; Boersma E; Serruys PW;
    Catheter Cardiovasc Interv; 2010 Jul; 76(1):41-9. PubMed ID: 20310019
    [TBL] [Abstract][Full Text] [Related]  

  • 39. What is the risk of stent thrombosis associated with the use of paclitaxel-eluting stents for percutaneous coronary intervention?: a meta-analysis.
    Bavry AA; Kumbhani DJ; Helton TJ; Bhatt DL
    J Am Coll Cardiol; 2005 Mar; 45(6):941-6. PubMed ID: 15766833
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term (>3 Years) outcome and predictors of clinical events after insertion of sirolimus-eluting stent in one or more native coronary arteries (from the Israeli arm of the e-Cypher registry).
    Planer D; Beyar R; Almagor Y; Banai S; Guetta V; Miller H; Kornowski R; Brandes S; Krakover R; Solomon M; Lotan C
    Am J Cardiol; 2008 Apr; 101(7):953-9. PubMed ID: 18359314
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.